Literature DB >> 9330840

Serotonin syndrome. A clinical update.

K C Mills1.   

Abstract

Serotonin syndrome is characterized by varied degrees of cognitive, autonomic, and neuromuscular dysfunction and can only be produced by drug therapy that increases central nervous system serotonin neurotransmission. Information gained from a retrospective review of 127 cases of serotonin syndrome is presented. It is not uncommon for severe cases of serotonin syndrome to be confused with neuroleptic malignant syndrome. Treatment is mainly supportive, but specific pharmacologic therapy with serotonin antagonists may be potentially beneficial.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9330840     DOI: 10.1016/s0749-0704(05)70368-7

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  25 in total

Review 1.  Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.

Authors:  P Egermayer; G I Town; A J Peacock
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

Review 2.  Serotonin syndrome: a brief review.

Authors:  Philippe Birmes; Dominique Coppin; Laurent Schmitt; Dominique Lauque
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

3.  Serotonin syndrome in the intensive care unit: clinical presentations and precipitating medications.

Authors:  Swetha Pedavally; Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

4.  Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease.

Authors:  Saki Manabe; Hidetaka Yanagi; Hideki Ozawa; Atsushi Takagi
Journal:  BMJ Case Rep       Date:  2019-02-28

5.  Serotonin syndrome.

Authors:  Charlotte Elizabeth Evans; Joseph Sebastian
Journal:  Emerg Med J       Date:  2007-04       Impact factor: 2.740

Review 6.  The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

Authors:  Edward M Mills; Daniel E Rusyniak; Jon E Sprague
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

Review 7.  [Rhabdomyolysis and myoglobinuria].

Authors:  A Lindner; S Zierz
Journal:  Nervenarzt       Date:  2003-05-14       Impact factor: 1.214

Review 8.  Movement disorder emergencies.

Authors:  Kathleen L Poston; Steven J Frucht
Journal:  J Neurol       Date:  2008-08       Impact factor: 4.849

9.  Fluoxetine overdose-induced seizure.

Authors:  Jeffrey R Suchard
Journal:  West J Emerg Med       Date:  2008-08

10.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.